rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2005-5-9
|
pubmed:abstractText |
Pituitary adenylate cyclase-activating polypeptide (PACAP) has been shown to play an important role in the regulation of islet function. We investigated its effects in beta-cell-specific calmodulin-overexpressing diabetic (CaMTg) mice, in which we consider that apoptosis of beta cells is the primary defect leading to basal hyperglycaemia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0804-4643
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
152
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
805-11
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15879367-Animals,
pubmed-meshheading:15879367-Blood Glucose,
pubmed-meshheading:15879367-Calmodulin,
pubmed-meshheading:15879367-Diabetes Mellitus, Experimental,
pubmed-meshheading:15879367-Gene Expression,
pubmed-meshheading:15879367-Hyperglycemia,
pubmed-meshheading:15879367-Insulin,
pubmed-meshheading:15879367-Islets of Langerhans,
pubmed-meshheading:15879367-Mice,
pubmed-meshheading:15879367-Mice, Inbred ICR,
pubmed-meshheading:15879367-Mice, Transgenic,
pubmed-meshheading:15879367-Nerve Growth Factors,
pubmed-meshheading:15879367-Neuropeptides,
pubmed-meshheading:15879367-Neurotransmitter Agents,
pubmed-meshheading:15879367-Pituitary Adenylate Cyclase-Activating Polypeptide
|
pubmed:year |
2005
|
pubmed:articleTitle |
Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice.
|
pubmed:affiliation |
Department of Endocrinology and Diabetology, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|